PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
25-Jul-2024 Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience Eisai Inc
24-Jul-2024 ImmunOs Therapeutics Expands Phase I Clinical Trial of IOS-1002 in Combination with KEYTRUDA® (pembrolizumab) for the Treatment of Solid Tumors ImmunOs Therapeutics
24-Jul-2024 Vitamin D Therapy Market Expected to Reach USD 7.5 Billion by 2032 Global Market Insights, Inc.
24-Jul-2024 Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases Sirnaomics Ltd.
24-Jul-2024 Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program Avance Clinical
23-Jul-2024 Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial PureTech Health
23-Jul-2024 ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer center ViroCell
23-Jul-2024 ViiV Healthcare announces positive data demonstrating 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy for maintenance therapy of HIV-1 ViiV Healthcare
23-Jul-2024 ViiV Healthcare announces positive new data for Apretude use during pregnancy at AIDS 2024 ViiV Healthcare
23-Jul-2024 ViiV Healthcare premieres early data showing antiviral activity against integrase resistance from its investigational, third-generation integrase inhibitor AIDS 2024 ViiV Healthcare
23-Jul-2024 Xeltis appoints Shawn Gage as Vice President of US Clinical Affairs Xeltis
22-Jul-2024 Avista Capital Partners and Hamilton Lane Announce Partnership in Cosette Pharmaceuticals Avista Capital Partners
22-Jul-2024 Transgene and BioInvent to Present Poster on Oncolytic Virus, BT-001, at ESMO 2024 Transgene
22-Jul-2024 Certa Therapeutics Receives EU Orphan Designation for FT011, a GPR68 Inhibitor Being Developed as an Anti-Fibrotic Treatment for Systemic Sclerosis Certa Therapeutics
22-Jul-2024 APOLLO THERAPEUTICS AND THE UNIVERSITY OF OXFORD ENTER INTO DRUG DISCOVERY AND DEVELOPMENT COLLABORATION Apollo Therapeutics
22-Jul-2024 Research reveals the greatest fear of life sciences tech leaders: cyber espionage NTT DATA
22-Jul-2024 APOLLO THERAPEUTICS AND THE UNIVERSITY OF OXFORD ENTER INTO DRUG DISCOVERY AND DEVELOPMENT COLLABORATION Apollo Therapeutics
22-Jul-2024 Pioneering biotech extends collaboration with leading global drug researcher to boost search for rare disease therapies SynaptixBio
22-Jul-2024 JPA Health Acquires London-based akt health communications A JPA Health Company
18-Jul-2024 There’s been a 21% increase in liver cirrhosis since 2019 and it’s not always linked to drink, says expert London Medical Laboratory